313TE targets IL-13Rα2-positive tumors in preclinical testing
A preclinical study reports that the IL-13E13Y-based T-cell engager 313TE linked IL-13Rα2-positive tumor cells to T cells, promoting receptor-dependent killing ...
A preclinical study reports that the IL-13E13Y-based T-cell engager 313TE linked IL-13Rα2-positive tumor cells to T cells, promoting receptor-dependent killing ...
A Ghanaian study of 38 children with non-Hodgkin lymphoma found that BCL-2 expression and tumor spread significantly predicted survival, with ...
A new grading system for tertiary lymphoid structures in glioblastoma tissue identifies patients with significantly longer survival and may guide ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine